Clinical Trial Update: Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating aromatase inhibitors alone and with growth hormone in adolescent boys with idiopathic short stature has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Drugs mentioned

• Aromatase inhibitors (aromatase inhibitor)
• Growth Hormone (somatropin)

Snippet

Sponsor: Nemours Children's Clinic | Conditions: Idiopathic Short Stature | Phase 3 | Status: COMPLETED | Results posted: 2018-06-07